Free Trial
NASDAQ:YTEN

Yield10 Bioscience (YTEN) Stock Price, News & Analysis

Yield10 Bioscience logo
$0.66 0.00 (0.00%)
(As of 11/20/2024 ET)

About Yield10 Bioscience Stock (NASDAQ:YTEN)

Key Stats

Today's Range
$0.66
$0.66
50-Day Range
$0.39
$1.22
52-Week Range
$0.35
$17.26
Volume
173 shs
Average Volume
4,443 shs
Market Capitalization
$441,463.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Stock News Headlines

Trump said you could learn something from this man
Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.
See More Headlines

YTEN Stock Analysis - Frequently Asked Questions

Yield10 Bioscience's stock was trading at $5.7432 on January 1st, 2024. Since then, YTEN stock has decreased by 88.5% and is now trading at $0.6589.
View the best growth stocks for 2024 here
.

Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced its quarterly earnings data on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) earnings per share for the quarter, beating analysts' consensus estimates of ($15.60) by $3.84. The specialty chemicals company earned $0.09 million during the quarter, compared to the consensus estimate of $0.22 million.

Yield10 Bioscience shares reverse split on the morning of Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), KushCo (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL).

Company Calendar

Last Earnings
11/09/2021
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Agricultural production - crops
Sub-Industry
Agriculture
Current Symbol
NASDAQ:YTEN
Employees
30
Year Founded
1992

Profitability

Net Income
$-14,450,000.00
Pretax Margin
-1,693.60%

Debt

Sales & Book Value

Annual Sales
$60,000.00
Book Value
($4.97) per share

Miscellaneous

Free Float
625,000
Market Cap
$441,463.00
Optionable
Not Optionable
Beta
1.42

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:YTEN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners